High affinity is insufficient for strong B cell activation by HIV broadly neutralising antibodies

Abstract HIV broadly neutralizing antibodies (bnAbs) have been widely studied, and inducing a robust broadly neutralizing response remains a goal for many human vaccine studies. Much research focusses on creating higher affinity antigens to target bnAb precursors, however this ignores the role of no...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Chloe Rees-Spear, Olivia Payne, Emma Touizer, Alan Kennedy, Luke Muir, Peter Thomas, Alyssa Thomas DeCruz, Rachel A. McKendry, Leo Swadling, Marit J. van Gils, James E. Voss, Laura E. McCoy
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Nature Portfolio 2026-05-01
coleção:	npj Vaccines
Acesso em linha:	https://doi.org/10.1038/s41541-026-01468-y
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!